Serum Cholinesterases, a Novel Marker of Clinical Activity in Inflammatory Bowel Disease: A Retrospective Case-Control Study

Table 2

Relationship between phenotype characteristics and serum ChE levels of patients with IBD.

Subjects	(%)	Serum ChE (μmol/L)
CD ()
Age at diagnosis (yr)
A1 (≤16)	1 (1.7%)	5938	0.893
A2 (17-40)	31 (51.7%)
A3 (>40)	28 (46.7%)
Disease localization
Ileal (L1)	22 (36.7%)		0.821
Colonic (L2)	7 (11.7%)
Ileocolonic (L3)	27 (45.0%)
Isolated upper disease (L4)	4 (6.7%)
Disease behavior
Nonstructuring/penetrating (B1)	40 (66.7%)		0.076
Structuring (B2)	12 (20.0%)
Penetrating (B3)	8 (13.3%)
UC ()
Disease extension
Ulcerative proctitis (E1)	11 (7.7%)		0.052
Left-sided UC (E2)	86 (60.6%)
Extensive (E3)	45 (31.7%)

Data shown as . Phenotype assessed according to the Montreal classification.